Coagulation Factor XIII, A1 Polypeptide (F13A1) (N-Term) Peptide
F13A1
Reactivité: Humain
Hôte: Synthetic
BP, WB
-
- Antigène Tous les produits F13A1
- F13A1 (Coagulation Factor XIII, A1 Polypeptide (F13A1))
- Protein Region
- N-Term
- Origine
- Humain
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Séquence
- LPTVELQGVV PRGVNLQEFL NVTSVHLFKE RWDTNKVDHH TDKYENNKLI
- Attributs du produit
- This is a synthetic peptide designed for use in combination with anti- F13A1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Stock
- -20 °C
- Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Antigène
- F13A1 (Coagulation Factor XIII, A1 Polypeptide (F13A1))
- Synonymes
- F13a Peptide, f13a1 Peptide, wu:fo83d04 Peptide, zgc:153334 Peptide, F13A1 Peptide, F13A Peptide, 1200014I03Rik Peptide, AI462306 Peptide, coagulation factor XIII A1 chain Peptide, coagulation factor XIII, A1 polypeptide b Peptide, coagulation factor XIII A chain Peptide, coagulation factor XIII, A1 subunit Peptide, F13a1 Peptide, f13a1b Peptide, F13A1 Peptide
- Sujet
-
This gene encodes the coagulation factor XIII A subunit. Coagulation factor XIII is the last zymogen to become activated in the blood coagulation cascade. Plasma factor XIII is a heterotetramer composed of 2 A subunits and 2 B subunits. The A subunits have catalytic function, and the B subunits do not have enzymatic activity and may serve as plasma carrier molecules. Platelet factor XIII is comprised only of 2 A subunits, which are identical to those of plasma origin. Upon cleavage of the activation peptide by thrombin and in the presence of calcium ion, the plasma factor XIII dissociates its B subunits and yields the same active enzyme, factor XIIIa, as platelet factor XIII. This enzyme acts as a transglutaminase to catalyze the formation of gamma-glutamyl-epsilon-lysine crosslinking between fibrin molecules, thus stabilizing the fibrin clot. It also crosslinks alpha-2-plasmin inhibitor, or fibronectin, to the alpha chains of fibrin. Factor XIII deficiency is classified into two categories: type I deficiency, characterized by the lack of both the A and B subunits, and type II deficiency, characterized by the lack of the A subunit alone. These defects can result in a lifelong bleeding tendency, defective wound healing, and habitual abortion.
Alias Symbols: F13A
Protein Size: 732 - ID gène
- 2162
- NCBI Accession
- NM_000129, NP_000120
- UniProt
- P00488
-
Vous êtes ici:
